These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9226325)

  • 1. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy.
    Ohara K; Okumura T; Tsuji H; Chiba T; Min M; Tatsuzaki H; Tsujii H; Akine Y; Itai Y
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):367-72. PubMed ID: 9226325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation tolerance of the liver in relation to the preserved functional capacity.
    Ohara K; Tsuji H; Tatsuzaki H; Okumura T; Kawashima M; Fuji H; Tsujii H; Itai Y
    Acta Oncol; 1994; 33(7):819-23. PubMed ID: 7993652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma.
    Kawashima M; Kohno R; Nakachi K; Nishio T; Mitsunaga S; Ikeda M; Konishi M; Takahashi S; Gotohda N; Arahira S; Zenda S; Ogino T; Kinoshita T
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1479-86. PubMed ID: 20605350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.
    Schaub SK; Apisarnthanarax S; Price RG; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1339-1348. PubMed ID: 30170100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
    Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
    Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.
    Price RG; Apisarnthanarax S; Schaub SK; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1349-1356. PubMed ID: 29932945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
    PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused radiation hepatitis after Bragg-peak proton therapy for hepatocellular carcinoma: CT findings.
    Okumura T; Itai Y; Tsuji H; Matsueda K; Matsuzaki Y; Tsujii H
    J Comput Assist Tomogr; 1994; 18(5):821-3. PubMed ID: 8089336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?
    Edeline J; Lenoir L; Boudjema K; Rolland Y; Boulic A; Le Du F; Pracht M; Raoul JL; Clément B; Garin E; Boucher E
    Ann Surg Oncol; 2013 Aug; 20(8):2518-25. PubMed ID: 23494107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-volume histogram analysis of patients with hepatocellular carcinoma regarding changes in liver function after proton therapy].
    Tsuji H; Okumura T; Maruhashi A; Hayakawa Y; Matsuzaki Y; Tanaka N; Osuga T; Tsujii H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Apr; 55(5):322-8. PubMed ID: 7784153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer.
    Rim CH; Park S; Woo JY; Seong J
    Strahlenther Onkol; 2018 Nov; 194(11):1017-1029. PubMed ID: 30105451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
    Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial.
    Bush DA; Hillebrand DJ; Slater JM; Slater JD
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S189-93. PubMed ID: 15508084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT evaluation of hepatic injury following proton beam irradiation: appearance, enhancement, and 3D size reduction pattern.
    Ahmadi T; Itai Y; Onaya H; Yoshioka H; Okumura T; Akine Y
    J Comput Assist Tomogr; 1999; 23(5):655-63. PubMed ID: 10524841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.